1. Home
  2. INVA

as of 02-18-2026 2:13pm EST

$23.36
$0.49
-2.05%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Founded: 1996 Country:
N/A
Employees: N/A City: BURLINGAME
Market Cap: 1.5B IPO Year: N/A
Target Price: $36.50 AVG Volume (30 days): 762.5K
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $16.52 - $23.91 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 13.23% Revenue Growth (next year): 8.58%
P/E Ratio: 15.72 Index: N/A
Free Cash Flow: N/A FCF Growth: +23.57%

AI-Powered INVA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 20 hours ago

AI Recommendation

hold
Model Accuracy: 70.44%
70.44%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: